[
  {
    "info": {
      "NCT": "NCT04907539",
      "Protocol_No": "RXC004/0002",
      "jit": "Caris",
      "trial_name": "Redx Pharma Plc RXC004/0002 "
    },
    "disease": {
      "summary": "Colorectal Cancer",
      "details": [
        {
          "code": "Colorectal Adenocarcinoma (COADREAD)",
          "selection": "include",
          "stage": "Metastatic;Stage IV"
        }
      ]
    },
    "query": {
      "nct": "NCT04907539",
      "title": "A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)",
      "current_status": "Recruiting",
      "status_verif_date": "May 2021",
      "last_update_date": "April 22, 2022",
      "trial_hold_status": "open",
      "sponsor": "Redx Pharma Plc",
      "brief_summary": "This is a Phase II, open label, multicentre, multi-arm, study to evaluate the preliminary efficacy and safety of RXC004 as monotherapy and in combination with nivolumab in patients with Ring finger protein 43 (RNF43) or R-spondin (RSPO) aberrated, microsatellite stable (MSS), colorectal cancer (CRC), that have progressed following current standard of care treatment.",
      "conditions": "Colorectal Cancer",
      "type": "Interventional",
      "phase": "Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Arm A: RXC004 monotherapy",
          "drug": "RXC004 | Denosumab | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Arm A: RXC004 monotherapy",
              "Gene": "RNF43",
              "Gene2": "Not available",
              "Type": "Abberration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RNF43 Abberration  "
            },
            {
              "cohort": "Arm A: RXC004 monotherapy",
              "Gene": "RSPO2",
              "Gene2": "Not available",
              "Type": "Abberration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RSPO2 Abberration  "
            },
            {
              "cohort": "Arm A: RXC004 monotherapy",
              "Gene": "RSPO3",
              "Gene2": "Not available",
              "Type": "Abberration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RSPO3 Abberration  "
            },
            {
              "cohort": "Arm A: RXC004 monotherapy",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "Microsatellite",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "unstable",
              "summary": "Microsatellite stable MSS "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Arm B: RXC004 + nivolumab",
          "drug": "RXC004 | Nivolumab | Denosumab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Arm B: RXC004 + nivolumab",
              "Gene": "RNF43",
              "Gene2": "Not available",
              "Type": "Abberration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RNF43 Abberration  "
            },
            {
              "cohort": "Arm B: RXC004 + nivolumab",
              "Gene": "RSPO2",
              "Gene2": "Not available",
              "Type": "Abberration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RSPO2 Abberration  "
            },
            {
              "cohort": "Arm B: RXC004 + nivolumab",
              "Gene": "RSPO3",
              "Gene2": "Not available",
              "Type": "Abberration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RSPO3 Abberration  "
            },
            {
              "cohort": "Arm B: RXC004 + nivolumab",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "Microsatellite ",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "unstable",
              "summary": "Microsatellite stable MSS  "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-20",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04907539\" target=\"_blank\">NCT04907539<\/a>"
    }
  }
]
